Literature DB >> 2442171

Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica.

H Nakashima, Y Kido, N Kobayashi, Y Motoki, M Neushul, N Yamamoto.   

Abstract

An aqueous extract from the marine red alga, Schizymenia pacifica has been tested in a cell free system for its effect on reverse transcriptase from avian retrovirus (avian myeloblastosis virus), and mammalian retrovirus (Rauscher murine leukemia virus). The extract inhibited reverse transcriptase from both these retroviruses but showed almost no effect, if any, on the activity of cellular DNA polymerase alpha and RNA polymerase II in vitro. Consequently it is unlikely to have an adverse effect on the growth of cultured cell. The inhibitory activity of the extract was stable over a relatively wide pH range (pH 1-11) and was not lost after pronase digestion. Inhibitory activity of the extract was lost after boiling at 100 degrees C in 0.67 N HCl, and after treatment with 100 mM NaIO4. The active principle in the extract has an apparent molecular weight in excess of 100,000 daltons. This new reverse transcriptase inhibitor is probably a polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442171     DOI: 10.1007/bf00390034

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Purification of a factor from Ehrlich ascites tumor cells specifically stimulating RNA polymerase II.

Authors:  K Sekimizu; N Kobayashi; D Mizuno; S Natori
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Structure-activity relationships and specificity of inhibition of DNA polymerases from normal and leukemia cells of man and from simian sarcoma virus by rifamycin derivatives.

Authors:  R A DiCioccio; B I Srivastava
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

6.  Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Authors:  E De Clercq
Journal:  Cancer Lett       Date:  1979-11       Impact factor: 8.679

7.  Inhibition of activities of DNA polymerase alpha, beta, gamma, and reverse transcriptase of L1210 cells by phosphonoacetic acid.

Authors:  H S Allaudeen; J R Bertino
Journal:  Biochim Biophys Acta       Date:  1978-10-24

8.  Inhibition of murine leukaemia virus reverse transcriptase by 2-halogenated polyadenylic acids.

Authors:  T Fukui; E De Clercq
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

9.  Forms of deoxyribonucleic acid produced by virions of the ribonucleic acid tumor viruses.

Authors:  K F Manly; D F Smoler; E Bromfeld; D Baltimore
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

10.  A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS.

Authors:  P Rous
Journal:  J Exp Med       Date:  1911-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

2.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.

Authors:  T S Tochikura; H Nakashima; Y Ohashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

4.  Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus.

Authors:  Mary Zoepfl; Rohini Dwivedi; Maggie C Taylor; Vitor H Pomin; Michael A McVoy
Journal:  Antiviral Res       Date:  2021-04-14       Impact factor: 10.103

Review 5.  Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review.

Authors:  Azin Ahmadi; Soheil Zorofchian Moghadamtousi; Sazaly Abubakar; Keivan Zandi
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

6.  Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton.

Authors:  Yu Zhong; Yoshiyuki Yoshinaka; Tadahiro Takeda; Noriko Shimizu; Sayaka Yoshizaki; Yoshio Inagaki; Shinobu Matsuda; Gisho Honda; Nobutaka Fujii; Naoki Yamamoto
Journal:  Antiviral Res       Date:  2005-03-27       Impact factor: 5.970

Review 7.  Marine compounds and their antiviral activities.

Authors:  Jarred Yasuhara-Bell; Yuanan Lu
Journal:  Antiviral Res       Date:  2010-03-23       Impact factor: 5.970

Review 8.  Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents.

Authors:  R Sagaya Jansi; Ameer Khusro; Paul Agastian; Ahmed Alfarhan; Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Rajakrishnan Rajagopal; Damia Barcelo; Amal Al-Tamimi
Journal:  Sci Total Environ       Date:  2020-11-07       Impact factor: 7.963

Review 9.  Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.

Authors:  Bimalendu Ray; Imran Ali; Subrata Jana; Shuvam Mukherjee; Saikat Pal; Sayani Ray; Martin Schütz; Manfred Marschall
Journal:  Viruses       Date:  2021-12-24       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.